EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 15-Dec-2025 23:11 ET (16-Dec-2025 04:11 GMT/UTC)

Two-drug combination could improve colorectal cancer therapy

University of Barcelona
Peer-Reviewed Publication

Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors are known — and it is usually treated with surgery, chemotherapy and radiotherapy, or biological therapies. Now, a study by the University of Barcelona reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help improve the clinical treatment of this type of cancer, the third most common worldwide.

Journal: Oncogene

Researchers develop wearable patch for early skin cancer detection

Atrium Health Wake Forest Baptist
Peer-Reviewed Publication

Researchers at Wake Forest University School of Medicine have developed a groundbreaking, battery-free wearable patch that could help detect skin cancer earlier and more accurately, potentially saving lives by making screening more accessible and less invasive.

Journal: npj Biomedical Innovations

How mathematical models shape the endgame of cervical cancer

China Anti-Cancer Association
Peer-Reviewed Publication

Mathematical modeling is transforming how the world fights cervical cancer.

Journal: Cancer Biology & Medicine

Rethinking how bone marrow works

Cincinnati Children's Hospital Medical Center
Peer-Reviewed Publication

New study led by researchers at Cincinnati Children’s proposes a way to combine previously separate data gathering approaches and concepts about blood cell formation into a more unified whole

Journal: Nature Immunology
Funder: NIH/National Institutes of Health

How is radiation therapy portrayed in art?

Wiley
Peer-Reviewed Publication

Analysis in the Journal of Medical Radiation Sciences found that overall, novels, poems, music, film, and paintings tend to depict radiation therapy as associated with fear, mystery, and fascination.

Journal: Journal of Medical Radiation Sciences

New drug combinations pave the way for personalised leukaemia therapies

National University of Singapore, Yong Loo Lin School of Medicine
Peer-Reviewed Publication

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a landmark review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid leukaemia (AML), one of the most aggressive and treatment-resistant blood cancers.

Journal: Nature Reviews Clinical Oncology

Strong evidence supports skin-to-skin contact after birth as standard care

Cochrane
Peer-Reviewed Publication

Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.

Journal: Cochrane Database of Systematic Reviews

Researchers find a new targeted approach to shut down prostate cancer growth

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B N-terminal acetylation (H2BNTac), an essential chemical mark of these enhancers. They further implicate two proteins, p300 and CBP, that add these marks and, along with androgen receptor, turn on enhancers and promote prostate cancer growth. The study is published in Nature Genetics.

Journal: Nature Genetics
Funder: NIH/National Cancer Institute

University of South Alabama scientist awarded national grant to uncover triggers for inflammatory reactions

University of South Alabama
Grant and Award Announcement

With a goal of providing new insights aimed at helping patients with cancer and autoimmune diseases avoid and better treat first infusion reactions (FIR), University of South Alabama scientist Michael R. Elliott, Ph.D., recently received a two-year R21 grant for $431,147 from the National Institute of Allergy and Infectious Diseases.

Breast cancer discovery could help prevent recurrence

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

New research from Cold Spring Harbor Laboratory's dos Santos lab shows that inhibiting the BPTF protein in mice can slow or stop the spread of ER+ breast cancer and keep tumors vulnerable to common hormone therapy. The team’s findings could someday help prevent breast cancer recurrence and lead to better patient outcomes.

Journal: Nature Communications
Funder: Pershing Square Sohn Cancer Research Alliance, Simons Foundation, Cold Spring Harbor Laboratory, Northwell Health, NIH/National Institutes of Health, NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences

62
63
64
65
66